Comparing the Efficacy of 75mg Versus 150mg Aspirin for the Prevention of Preeclampsia in High-Risk Pregnant Women

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-30
SponsorShalamar Hospital

About this trial

This study aims to evaluate the effectiveness of 75 mg aspirin versus 150 mg aspirin in preventing preeclampsia among individuals with high risk for the condition. Existing literature suggests that the 150 mg aspirin dose may exhibit superior efficacy, yet inconclusive evidence exists in our local setting.

Eligibility criteria

Qualifiers

Screen positive women

Age 18 - 30 y

Gestational Age 11 - 13+6 weeks

Singleton Pregnancy

Disqualifiers

Screen negative women

Age > 30 y

Gestational Age > 14 weeks

Multiple Gestation

Trial design

Treatments tested in this trial

  • Aspirin 75 mg
  • Aspirin 150 mg

Treatment groups

340 Participants
are divided into 2 treatment groups

Sponsors and collaborators